Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price. The South ...
HELENA — Data released as part of a recently settled freedom-of-information lawsuit show that PPL Montana spent more than $127 million over eight years in capital improvements at the Colstrip power ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback